13F Holdings
中文EN

ANGO ANGIODYNAMICS INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1275187 · Fiscal year ends 05/31

Financial factors as of 2026-08-31 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.2%
TTM net income YoY-2.6%
TTM EPS YoY-1.3%
Revenue 3-yr CAGR-1.1%
Net income 3-yr CAGR—

Margins

Gross margin55.7%
Operating margin-11.2%
Net margin-10.1%
FCF margin0.4%
EBITDA margin-4.3%

Returns

ROE-19.2%
ROA-13.0%
ROIC (approx.)-21.4%
Asset turnover1.28x

Leverage & solvency

Liabilities / assets32.2%
Debt / equity0.00x
Current ratio2.40x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.11x
Accruals ratio-14.4%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-05-31FY20252025-05-31FY20242024-05-31FY20232023-05-31FY20222022-05-31
Income statement
Revenue$320.17M$292.50M$303.91M$338.75M$316.22M
Cost of revenue$145.28M$134.79M$149.22M$164.51M$150.49M
Gross profit$174.89M$157.71M$154.70M$174.25M$165.73M
R&D expense$29.45M$26.22M$31.51M$29.88M$30.74M
SG&A expense$43.69M$42.09M$41.16M$40.00M$38.45M
Operating income-$39.93M-$39.95M-$192.44M-$51.18M-$28.47M
Interest expense——-$1.61M$2.70M$688,000
Pretax income-$36.30M-$34.03M-$191.64M-$54.44M-$29.95M
Income tax$442,000-$39,000-$7.29M-$2.00M-$3.40M
Net income-$36.74M-$33.99M-$184.35M-$52.44M-$26.55M
EBITDA-$16.97M-$14.15M-$164.72M-$20.31M$878,000
EPS (basic)-0.88-0.83-4.59-1.33-0.68
EPS (diluted)-0.88-0.83-4.59-1.33-0.68
Weighted avg. shares (diluted)41.53M40.85M40.18M39.48M39.01M
Balance sheet
Cash & equivalents$53.86M$55.89M$76.06M$44.62M$28.82M
Receivables$48.33M$42.89M$43.61M$52.83M$52.30M
Inventory$52.44M$62.01M$60.62M$55.33M$51.39M
Current assets$163.39M$168.32M$193.25M$163.54M$143.34M
PP&E, net$27.10M$32.30M$35.67M$44.38M$45.01M
Goodwill——$0$159.24M$201.06M
Intangibles$67.21M$69.12M$77.38M$111.14M$152.38M
Total assets$267.16M$280.14M$317.67M$532.64M$552.75M
Current liabilities$74.72M$76.20M$91.16M$83.83M$74.32M
Long-term debt——$0$49.82M$25.00M
Total debt——$0$49.82M$25.00M
Total liabilities$96.34M$97.17M$112.08M$154.34M$128.26M
Shareholders' equity$170.82M$182.97M$205.59M$378.30M$424.49M
Net debt——-$76.06M$5.20M-$3.83M
Shares outstanding41.70M40.99M40.43M39.61M39.17M
Cash flow statement
Operating cash flow$3.09M-$10.13M-$28.16M$78,000-$7.19M
Capital expenditure$2.58M$4.46M$2.52M$3.81M$4.30M
Free cash flow$508,000-$14.59M-$30.68M-$3.73M-$11.49M
Investing cash flow-$5.95M-$10.18M$123.72M-$9.75M-$19.31M
Financing cash flow$564,000-$255,000-$64.25M$25.42M$7.68M
Depreciation & amortization$22.95M$25.80M$27.71M$30.87M$29.35M
Stock-based compensation$13.96M$9.77M$10.53M$11.16M$10.69M
Share buybacks$0$1.67M$0$0—

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.